J7345 — Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
J7345 is a HCPCS Level II code for aminolevulinic acid hcl for topical administration, 10% gel, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
Medically Unlikely Edits — units per day
The most units of J7345 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.
- practitioner
- 600 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
- outpatient
- 600 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
- DME supplier
- 600 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.
The CMS record for J7345
- Long descriptor
- Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
- Short descriptor
- Aminolevulinic acid, 10% gel
- Added
- January 1, 2018
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7345
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7345 is not quite right, the correct code is very often within a few positions of it.
- J7330Autologous cultured chondrocytes, implant
- J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
- J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
- J7333Hyaluronan or derivative, visco-3, for intra-articular injection, per doseterminated
- J7335Capsaicin 8% patch, per 10 square centimetersterminated
- J7336Capsaicin 8% patch, per square centimeter
- J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
- J7342Instillation, ciprofloxacin otic suspension, 6 mg
- J7351Injection, bimatoprost, intracameral implant, 1 microgram
- J7352Afamelanotide implant, 1 mg
- J7353Anacaulase-bcdb, 8.8% gel, 1 gram
- J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- J7355Injection, travoprost, intracameral implant, 1 microgram
- J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
- J7401Mometasone furoate sinus implant, 10 microgramsterminated
- J7402Mometasone furoate sinus implant, (sinuva), 10 micrograms
Questions about J7345
What is HCPCS code J7345?
J7345 is a HCPCS Level II code for aminolevulinic acid hcl for topical administration, 10% gel, 10 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7345?
The CMS HCPCS file marks J7345 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is J7345 paid under the physician fee schedule?
J7345 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).